Evidence map›Paper›PMID 26068045›Full record

ArticleCirculation2015

Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility.

Indira Medina, Céline Cougoule, Maik Drechsler, Beatriz Bermudez, Rory R Koenen, Judith Sluimer, Ine Wolfs, Yvonne Döring, Veronica Herias, Marjon Gijbels and 10 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Circulation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Immune cell subset differentiation and tissue inflammation.Journal of hematology & oncology · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 1 institution in 2 countries.

Indira MedinaExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Céline Cougoule *CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France.
Maik Drechsler *Institute for Prevention of Cardiovascular Prevention (IPEK), LMU Munich, Germany.
Beatriz BermudezExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Rory R KoenenInstitute for Prevention of Cardiovascular Prevention (IPEK), LMU Munich, Germany.
Judith SluimerExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Ine WolfsExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Yvonne DöringInstitute for Prevention of Cardiovascular Prevention (IPEK), LMU Munich, Germany.
Veronica HeriasExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Marjon GijbelsExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Ilze BotDivision of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden University, Leiden, the Netherlands.
Saskia de JagerDivision of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden University, Leiden, the Netherlands.
Christian WeberInstitute for Prevention of Cardiovascular Prevention (IPEK), LMU Munich, Germany.
Jack CleutjensExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Theo J C van BerkelDivision of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden University, Leiden, the Netherlands.
Kees-Jan SikkinkDepartment of Vascular Surgery, Orbis Hospital Sittard, The Netherlands.
Atilla MócsaiDepartment of Physiology; Semmelweis University, Budapest, Hungary.
Isabelle Maridonneau-PariniCNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France.
Oliver SoehnleinInstitute for Prevention of Cardiovascular Prevention (IPEK), LMU Munich, Germany.
Erik A L BiessenExperimental Vascular Pathology group, Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Centre National de la Recherche Scientifique · FR

Funding

European Research Council 206283Wellcome Trust 087782
6 · The paper itself

Abstract

backgroundLeukocyte migration is critical for the infiltration of monocytes and accumulation of monocyte-derived macrophages in inflammation. Considering that Hck and Fgr are instrumental in this process, their impact on atherosclerosis and on lesion inflammation and stability was evaluated. METHODS AND

resultsHematopoietic Hck/Fgr-deficient, LDLr(-/-) chimeras, obtained by bone marrow transplantation, had smaller but, paradoxically, less stable lesions with reduced macrophage content, overt cap thinning, and necrotic core expansion as the most prominent features. Despite a Ly6C(high)-skewed proinflammatory monocyte phenotype, Hck/Fgr deficiency led to disrupted adhesion of myeloid cells to and transmigration across endothelial monolayers in vitro and atherosclerotic plaques in vivo, as assessed by intravital microscopy, flow cytometry, and histological examination of atherosclerotic arteries. Moreover, Hck/Fgr-deficient macrophages showed blunted podosome formation and mesenchymal migration capacity. In consequence, transmigrated double-knockout macrophages were seen to accumulate in the fibrous cap, potentially promoting its focal erosion, as observed for double-knockout chimeras.

conclusionsThe hematopoietic deficiency of Hck and Fgr led to attenuated atherosclerotic plaque formation by abrogating endothelial adhesion and transmigration; paradoxically, it also promoted plaque instability by causing monocyte subset imbalance and subendothelial accumulation, raising a note of caution regarding src kinase-targeted intervention in plaque inflammation.

Indexed as

AnimalsApoptosisCell AdhesionCells, CulturedCell Surface ExtensionsChemotaxis, LeukocyteEndothelial CellsExtracellular Matrix ProteinsFemaleGene Expression ProfilingHumansLeukocyte RollingMacrophages, PeritonealMiceMice, Inbred C57BLMice, KnockoutExtracellular Matrix ProteinsHck protein, mouseProto-Oncogene Proteinsproto-oncogene proteins c-fgrProto-Oncogene Proteins c-hckReceptors, LDLsrc-Family Kinasesatherosclerosiscell migration assaysimmunologyleukocytesmobilityphosphotransferasesplaque, atherosclerotic

Identifiers

PMID26068045
PMCPMC4535360
OpenAlexW1923641401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.